长期后续:一种新的,准确和高效的基于NGS的方法用于帕金森病中的GBA1分析
Giada Cuconato1, Ilaria Palmieri2, Marco Percetti3
1Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Parkinsonism & related disorders
|March 29, 2025
概括
LONG-NEXT是一种新的NGS策略,可以准确地测序GBA1基因,克服其伪基因所带来的挑战. 这种方法通过减少传统测序技术的错误来改善帕金森病遗传测试.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- GBA1基因中的遗传变异是帕金森病 (PD) 的主要遗传风险因素.
- 目前的大规模GBA1测序方法,如桑格和短读下一代测序 (sr-NGS),是繁的,容易出现错误.
- GBA1与其伪基 (GBA1LP) 之间的高序列同质性使准确的测序变得复杂,导致假阳性和假阴性.
研究的目的:
- 设计,优化和验证LONG-NEXT,一种基于NGS的新策略,用于简化,大规模的GBA1测序.
- 为了解决与GBA1测序相关的诊断不准确性,由于其伪基因.
主要方法:
- LONG-NEXT采用特定的远程PCR来在单片段中放大整个GBA1基因 (6.5kb).
- 短读NGS在放大片段上进行.
- 一个定制的生物信息管道掩盖了参考基因组上的GBA1LP序列,以确保准确的GBA1读取映射.
主要成果:
- 使用常规方法对13个疑似错误的病例进行了重新分析,发现了3个假阳性,4个假同位素和6个假阴性.
- 在101名桑格测序和294名sr-NGS查PD患者的验证中,发现了另外一个假同位素和一个假阴性.
- LONG-NEXT成功地纠正了之前的诊断错误,证明了其改进的准确性.
结论:
- LONG-NEXT为GBA1基因测序提供了一种可靠,快速和低成本的替代方案.
- 这种方法对于识别可能受益于基因型特异性治疗的GBA1-PD患者具有战略意义.
- LONG-NEXT提高了帕金森病遗传诊断的准确性.
更多相关视频
04:08Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
3.3K
06:09Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
5.0K
相关概念视频
03:00Next-generation Sequencing
88.0K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.0K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34